Influence of the conditioning regimens on the incidence of mixed chimerism in thalassemic transplanted patients.
Manna
M
M
Divisione di Ematologia, Ospedale di Muraglia, U.S.L. 3, Pesaro, Italia.
Nesci
S
S
Andreani
M
M
Tonucci
P
P
Lucarelli
G
G
D000293:Adolescent; D000328:Adult; D000961:Antilymphocyte Serum; D001853:Bone Marrow / Q000187:drug effects / Q000473:pathology*; D016465:Bone Marrow Purging / Q000379:methods*; D016026:Bone Marrow Transplantation; D002066:Busulfan; D002470:Cell Survival; D002648:Child; D002675:Child, Preschool; D002678:Chimera; D003520:Cyclophosphamide; D016572:Cyclosporine; D004247:DNA / Q000235:genetics; D006085:Graft Survival; D006412:Hematopoietic Stem Cells / Q000187:drug effects; D006801:Humans; D008727:Methotrexate; D012150:Polymorphism, Restriction Fragment Length; D017086:beta-Thalassemia / Q000235:genetics / Q000276:immunology / Q000473:pathology / Q000601:surgery*
D000961:Antilymphocyte Serum; D016572:Cyclosporine; D003520:Cyclophosphamide; D004247:DNA; D002066:Busulfan; D008727:Methotrexate